Wiley Bros. Aintree Capital, LLC Takeda Pharmaceutical CO LTD Call Options Transaction History
Wiley Bros. Aintree Capital, LLC
- $2.26 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TAK
# of Institutions
321Shares Held
67.8MCall Options Held
939KPut Options Held
233K-
Capital Research Global Investors Los Angeles, CA13.1MShares$182 Million0.04% of portfolio
-
Mondrian Investment Partners LTD London, X05.09MShares$70.6 Million1.21% of portfolio
-
Morgan Stanley New York, NY4.99MShares$69.1 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.35MShares$60.2 Million0.03% of portfolio
-
Goldman Sachs Group Inc New York, NY3.72MShares$51.5 Million0.01% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $43.1B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...